Mirxes Founders and Cornerstone Investor Extend Shareholding Lock-Up to Back Growth Plans

The latest update is out from Mirxes Holding Company Limited ( (HK:2629) ).

Mirxes Holding Company Limited announced that its three co-founders and cornerstone investor Beijing Xunrui Enterprise Management Partnership will extend their commitment to the company’s shares after the current lock-up expires on February 23, 2026. For 12 months thereafter, the co-founders will not sell any of their respective holdings, while the cornerstone investor will retain at least 80% of its stake.

The move signals strong confidence in Mirxes’ long-term prospects, business fundamentals and strategic direction, reinforcing their stance as long-term shareholders. It also underscores support for the company’s recent initiatives in mergers and acquisitions, R&D advancement in multi-cancer early detection solutions, and expansion into emerging markets, which may bolster investor perception of stability and growth potential.

More about Mirxes Holding Company Limited

Mirxes Holding Company Limited is a Cayman Islands-incorporated company listed in Hong Kong, operating in the biotechnology and diagnostics sector. The group focuses on research and development of advanced diagnostic solutions, including multi-cancer early detection technologies, with a strategy that includes mergers and acquisitions and expansion into emerging markets.

Average Trading Volume: 973,043

Technical Sentiment Signal: Strong Sell

Current Market Cap: HK$6.76B

See more data about 2629 stock on TipRanks’ Stock Analysis page.